시장보고서
상품코드
1469144

고주파 소작 디바이스 시장 : 세계 산업 규모, 동향, 기회, 예측, 컴포넌트 유형별, 용도별, 최종 용도별, 지역별, 경쟁별(2019-2029년)

Radiofrequency Ablation Devices Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Component Type, By Application, By End Use, By Region, and By Competition, 2019-2029F

발행일: | 리서치사: TechSci Research | 페이지 정보: 영문 185 Pages | 배송안내 : 2-3일 (영업일 기준)

    
    
    


■ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.

※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

세계의 고주파 소작 디바이스 시장은 2023년에 42억 5,000만 달러로 평가되며, 2029년까지의 CAGR은 11.60%로 예측됩니다.

세계의 고주파 소작 디바이스 시장이란 고주파 소작 요법(RFA)으로 불리는 저침습 시술에 사용되는 의료기기의 생산과 유통에 초점을 맞춘 세계의 산업을 가리킵니다. RFA는 다양한 병상의 치료에 이용되는 의료 기술이며, 특히 만성 통증 및 일부 종류의 암 치료에 이용됩니다. 이 시장은 의료 기술의 진보와 저침습 시술의 수요 증가에 의해 최근 대폭적인 성장을 달성하고 있습니다.

주요 시장 촉진요인

만성 통증의 유병률 상승

종양학에서 용도의 확대

저침습수술

고령화 인구의 증가

주요 시장이 해결해야 할 과제

상환 문제

대체 요법과의 경쟁

경제적 제약

주요 시장 동향

인공지능(AI)의 출현

원격 모니터링과 원격 수술

컴팩트·휴대용 기기

부문별 인사이트

컴포넌트 유형별 인사이트

용도별 인사이트

지역별 인사이트

목차

제1장 개요

제2장 조사 방법

제3장 주요 요약

제4장 고객의 소리

제5장 세계의 고주파 소작 디바이스 시장 전망

  • 시장 규모 예측
    • 금액별
  • 시장 점유율 예측
    • 컴포넌트 유형별(일회용 장비, 캐피탈 장비, 리유저블 장비)
    • 용도별(외과 종양학, 심장병학 심장 박동 관리, 미용학, 부인과학, 통증 관리)
    • 최종 용도별(병원, 외래 수술 센터, 연구소, 기타)
    • 지역별
    • 기업별(2023년)
  • 시장 맵
    • 컴포넌트 유형별
    • 용도별
    • 최종 용도별
    • 지역별

제6장 북미의 고주파 소작 디바이스 시장 전망

  • 시장 규모 예측
    • 금액별
  • 시장 점유율 예측
    • 컴포넌트 유형별
    • 용도별
    • 최종 용도별
    • 국가별
  • 북미 : 국가별 분석
    • 미국
    • 캐나다
    • 멕시코

제7장 유럽의 고주파 소작 디바이스 시장 전망

  • 시장 규모 예측
    • 금액별
  • 시장 점유율 예측
    • 컴포넌트 유형별
    • 용도별
    • 최종 용도별
    • 국가별
  • 유럽 국가별 분석
    • 독일
    • 영국
    • 프랑스
    • 이탈리아
    • 스페인

제8장 아시아태평양의 고주파 소작 디바이스 시장 전망

  • 시장 규모 예측
    • 금액별
  • 시장 점유율 예측
    • 컴포넌트 유형별
    • 용도별
    • 최종 용도별
    • 국가별
  • 아시아태평양 국가별 분석
    • 중국
    • 일본
    • 인도
    • 호주
    • 한국

제9장 남미의 고주파 소작 디바이스 시장 전망

  • 시장 규모 예측
    • 금액별
  • 시장 점유율 예측
    • 컴포넌트 유형별
    • 용도별
    • 최종 용도별
    • 국가별
  • 남미 : 국가별 분석
    • 브라질
    • 아르헨티나
    • 콜롬비아

제10장 중동 및 아프리카의 고주파 소작 디바이스 시장 전망

  • 시장 규모 예측
    • 금액별
  • 시장 점유율 예측
    • 컴포넌트 유형별
    • 용도별
    • 최종 용도별
    • 국가별
  • MEA : 국가별 분석
    • 남아프리카공화국
    • 사우디아라비아
    • 아랍에미리트
    • 쿠웨이트

제11장 시장 역학

  • 촉진요인
  • 과제

제12장 시장 동향과 발전

  • 최근 도입
  • 합병·인수
  • 제품 출시

제13장 Porter's Five Forces 분석

  • 업계내의 경쟁
  • 신규 참여의 가능성
  • 공급업체의 힘
  • 고객의 힘
  • 대체품의 위협

제14장 경쟁 구도

  • Boston Scientific Corporation
  • Medtronic plc
  • Stryker Corporation
  • Abbott Laboratories, Inc.
  • Smith Nephew PLC
  • Johnson Johnson
  • AngioDynamics Inc

제15장 전략적 제안

제16장 면책사항

KSA 24.05.17

Global Radiofrequency Ablation Devices Market was valued at USD 4.25 billion in 2023 and is anticipated to project impressive CAGR of 11.60% through 2029. The Global Radiofrequency Ablation Devices Market refers to the worldwide industry focused on the production and distribution of medical devices used in a minimally invasive procedure called radiofrequency ablation (RFA). RFA is a medical technique employed to treat a variety of medical conditions, most notably chronic pain and certain types of cancer. This market has seen substantial growth in recent years due to advancements in medical technology and increasing demand for minimally invasive procedures.

Key Market Drivers

Rising Prevalence of Chronic Pain

Chronic pain presents a significant health challenge globally, impacting millions and diminishing their quality of life, productivity, and emotional well-being. As this issue escalates, the Global Radiofrequency Ablation Devices Market experiences substantial growth, offering a promising solution for chronic pain management.Radiofrequency ablation (RFA) emerges as a minimally invasive treatment option, targeting specific nerve fibers transmitting pain signals. Commonly used to alleviate conditions like spinal arthritis and chronic back pain, RFA precisely targets pain sources while preserving surrounding healthy tissue. Its outpatient nature and minimal incisions reduce surgical risks, offering sustained pain relief compared to temporary medications.

The prevalence of chronic pain conditions, influenced by sedentary lifestyles and aging populations, fuels demand for RFA devices. Increasing awareness among patients and healthcare providers about minimally invasive alternatives drives market growth. Ongoing technological innovations enhance RFA procedures, improving patient outcomes and expanding treatable conditions.Healthcare providers prioritize patient-centric care, emphasizing pain management and comfort. RFA aligns with this approach, offering tailored pain relief solutions that are cost-effective compared to long-term medication use or other treatments. As healthcare systems seek efficient and economically viable options, RFA emerges as a practical solution in chronic pain management.

Expanding Applications in Oncology

Cancer, a leading global cause of mortality, has driven significant advancements in medical technology, with radiofrequency ablation (RFA) emerging as a promising minimally invasive tool for certain cancer types. The expanding applications of RFA in oncology are key drivers behind the growth of the Global Radiofrequency Ablation Devices Market.RFA is extensively used to treat hepatocellular carcinoma (HCC), the most prevalent liver cancer type. It provides a less invasive option for patients ineligible for surgical resection and can serve as a bridge to liver transplantation. RFA also addresses lung tumors, particularly beneficial in surgically challenging locations. It is an alternative for small renal tumors, prioritizing kidney function preservation. Additionally, RFA offers palliative care for bone metastases, alleviating pain and enhancing patients' quality of life.

With the global cancer burden increasing due to population growth, aging demographics, and lifestyle changes, demand for innovative treatments like RFA rises. Its minimally invasive approach appeals to patients and healthcare providers, offering benefits such as reduced post-operative pain, shorter hospital stays, and faster recovery times. Advancements in RFA technology enable more precise and efficient devices, enhancing tumor targeting accuracy and patient outcomes.Compared to surgery, RFA procedures often result in lower morbidity, making them preferable for older or frail patients. RFA's compatibility with other cancer treatments, like surgery, chemotherapy, or radiation therapy, supports holistic cancer management. Moreover, RFA is considered cost-effective, particularly when it reduces hospitalization time and associated expenses.

Minimally Invasive Procedures

In the dynamic healthcare landscape, minimally invasive procedures have become the preferred choice for both patients and medical professionals. Among these, radiofrequency ablation (RFA) stands out as a pioneering technique, offering precise and effective treatment options for various medical conditions. The global RFA market is witnessing significant growth, driven by the increasing popularity of minimally invasive procedures.Minimally invasive procedures, characterized by small incisions, mitigate the risks of complications, infections, and post-operative pain. They often entail minimal blood loss compared to traditional surgery and result in shorter hospital stays, leading to reduced healthcare costs and faster recoveries. Patients benefit from a quicker return to their daily activities and less noticeable scars, particularly significant for cosmetic or sensitive areas.

With a growing awareness of healthcare options, patients are increasingly choosing minimally invasive procedures for their potential benefits such as reduced pain, shorter recovery times, and minimized scarring. Medical professionals are also recognizing the advantages of these procedures, providing efficient and cost-effective treatments. Ongoing advancements in RFA technology enhance the precision and effectiveness of these procedures, expanding their applications across various medical fields.Healthcare systems are increasingly embracing minimally invasive treatments like RFA due to their potential cost savings compared to traditional surgery. Beyond pain management, RFA finds applications in oncology and other medical domains, highlighting its versatility as a tool in minimally invasive medicine.

Growing Aging Population

The global demographic landscape is undergoing a significant transformation characterized by a rapidly expanding aging population. This demographic shift is not only reshaping healthcare services but also influencing the medical device industry, particularly the Global Radiofrequency Ablation Devices Market, which specializes in minimally invasive treatments.

The aging of the population stems from several factors, including increased life expectancy, declining birth rates, and advancements in healthcare that prolong life and improve access to medical care. While indicative of progress in healthcare and living standards, the aging population presents challenges, notably a rise in age-related health conditions such as osteoarthritis, chronic pain, and various cancers.Minimally invasive procedures like RFA are particularly beneficial for seniors due to their smaller incisions, reduced blood loss, and shorter hospital stays. These factors are crucial for older individuals, who may have diminished physiological resilience and heightened susceptibility to complications associated with open surgeries. RFA effectively manages chronic pain conditions prevalent among seniors, often leading to decreased postoperative pain and an enhanced overall quality of life. Additionally, for seniors with advanced-stage cancers or metastatic diseases, RFA provides palliative care, offering pain relief and improving their quality of life in a minimally invasive manner.

The expanding size of the aging population is a primary driver of the Global Radiofrequency Ablation Devices Market's growth. As the elderly demographic continues to grow, so does the demand for treatments like RFA tailored to their specific healthcare needs. With advancements in healthcare and lifestyle improvements, people are living longer, resulting in a higher prevalence of age-related medical conditions that can be addressed through RFA procedures. Seniors, like other demographic groups, increasingly favor minimally invasive procedures due to their reduced complication risks and faster recovery times.Continual technological advancements in RFA devices further enhance procedure safety and effectiveness, making them increasingly appealing to both patients and healthcare providers. Moreover, RFA is often deemed a cost-effective alternative to traditional surgeries, aligning with the economic constraints faced by healthcare systems.

Key Market Challenges

Reimbursement Issues

Reimbursement policies significantly affect the adoption of RFA procedures. The variability in reimbursement levels for RFA treatments across different healthcare systems and insurance providers poses a challenge. In some cases, RFA may not be adequately reimbursed, making it less accessible to patients and healthcare providers. Addressing this challenge is crucial to ensure that RFA remains a viable and cost-effective option for patients.

Competition from Alternative Therapies

The Global Radiofrequency Ablation Devices Market faces competition from alternative therapies and treatment options. Surgery, traditional pain management techniques, and emerging treatments such as cryoablation and microwave ablation offer alternatives to RFA. Healthcare providers and patients may need convincing that RFA is the best option for their specific needs, especially as the landscape of medical treatments continues to evolve.

Economic Constraints

The economic challenges within healthcare systems worldwide can impact the growth of the RFA market. Economic pressures on healthcare institutions, cost containment efforts, and budget constraints can influence decision-makers to opt for lower-cost alternatives, even if RFA may provide better patient outcomes in the long run. Convincing healthcare systems of the long-term cost-effectiveness of RFA is an ongoing challenge.

Key Market Trends

Emergence of Artificial Intelligence (AI)

Artificial intelligence is finding its way into the healthcare sector, and the RFA market is no exception. AI can be used to enhance the precision of RFA procedures by assisting in treatment planning, targeting tumors with greater accuracy, and providing real-time feedback during the procedure. AI-driven technologies are expected to improve patient outcomes and reduce the margin of error in RFA treatments.

Remote Monitoring and Telesurgery

The integration of telemedicine and remote monitoring is becoming increasingly prevalent in the healthcare industry. In the RFA market, this trend is expected to enable real-time monitoring of patients who have undergone RFA procedures. Healthcare providers can remotely assess patient progress, identify potential issues, and offer immediate support if necessary. This not only enhances patient care but also reduces the need for frequent in-person follow-ups.

Compact and Portable Devices

Advancements in RFA technology are leading to the development of smaller, more portable devices. These compact systems can be used in various clinical settings, including outpatient clinics, and can expand access to RFA procedures. Smaller devices may also reduce the cost and complexity of the procedures, making RFA more accessible to a wider range of patients.

Segmental Insights

Component Type Insights

Based on the category of Component Type, disposable equipment held the largest market share in 2023 and is anticipated to exhibit the highest CAGR during the projected period.Disposable equipment comprises single-use devices such as catheters, probes, electrodes, and other consumables essential for Radiofrequency Ablation (RFA) procedures. This segment holds a prominent position in the market, primarily due to its volume dominance. Each procedure necessitates new disposable items to uphold sterility and safety standards. Healthcare providers favor disposable equipment for its convenience, minimized risk of cross-contamination, and avoidance of sterilization expenses. Moreover, the disposability ensures consistent performance, mitigating device-related complications. The segment's dominance is further fueled by the escalating global demand for RFA procedures and the rising prevalence of chronic pain conditions.

Application Insights

Based on Application, Pain Management emerged as the dominant player in the market for the year 2023.Pain management accounts for a significant share of the market due to the widespread prevalence of chronic pain conditions globally. Chronic pain affects millions of individuals, impacting their quality of life and productivity. Radiofrequency ablation (RFA) procedures offer an effective solution for managing chronic pain by targeting the nerves responsible for transmitting pain signals.

In pain management, RFA is commonly used to treat conditions such as chronic back pain, arthritis-related pain, neuropathic pain, and cancer-related pain. RFA procedures involve the use of thermal energy to selectively destroy nerves, thereby providing long-lasting pain relief. Compared to traditional pain management techniques like medication or surgery, RFA offers several advantages, including reduced reliance on opioids, fewer side effects, and improved functional outcomes.The growing preference for minimally invasive procedures among patients and healthcare providers has contributed to the dominance of pain management in the RFA devices market. Minimally invasive techniques like RFA offer quicker recovery times, shorter hospital stays, and lower complication rates compared to open surgery, making them highly attractive for pain management.

The aging population, coupled with the rising incidence of chronic pain conditions, further drives the demand for RFA devices in pain management. As the global burden of chronic pain continues to increase, the market for RFA devices in pain management is expected to expand significantly in the coming years. Additionally, ongoing advancements in RFA technology, such as improved device design and precision, are likely to further enhance the efficacy and accessibility of RFA procedures for pain management.

Regional Insights

North America dominated in terms of revenue in 2023, and it is poised to maintain its leadership position throughout the forecast period.North America, particularly the United States, boasts a highly advanced healthcare infrastructure with state-of-the-art facilities and equipment. Hospitals and healthcare institutions in the region are well-equipped to perform radiofrequency ablation (RFA) procedures, ensuring accessibility and availability of treatment options for patients. The region is a hub for medical device innovation, with numerous companies and research institutions driving advancements in RFA technology. Continuous research and development efforts have led to the development of more precise, efficient, and user-friendly RFA devices, enhancing procedural outcomes and patient safety. The United States allocates a significant portion of its gross domestic product (GDP) to healthcare spending, indicating a strong financial investment in healthcare services and technologies. This substantial healthcare expenditure supports the adoption and utilization of advanced medical technologies like RFA devices, contributing to market dominance. North America faces a growing burden of chronic diseases such as chronic pain conditions, cardiac arrhythmias, and cancer. RFA procedures are widely used in the management of these conditions, driving the demand for RFA devices in the region. The prevalence of chronic diseases, coupled with an aging population, further fuels market growth.

Key Market Players

Boston Scientific Corporation

Medtronic plc.

Stryker Corporation

Abbott Laboratories, Inc

Smith Nephew PLC

Johnson Johnson

AngioDynamics Inc

Report Scope:

In this report, the Global Radiofrequency Ablation Devices Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Radiofrequency Ablation Devices Market,By Component Type:

  • Disposable Equipment
  • Capital Equipment
  • Reusable Equipment

Radiofrequency Ablation Devices Market,By Application:

  • Surgical Oncology
  • Cardiology Cardiac Rhythm Management
  • Cosmetology
  • Gynecology
  • Pain Management

Radiofrequency Ablation Devices Market,By End Use:

  • Hospitals
  • Ambulatory Surgery Centers
  • Research Laboratories
  • Others

Radiofrequency Ablation Devices Market, By Region:

  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • Germany
    • United Kingdom
    • France
    • Italy
    • Spain
  • Asia-Pacific
    • China
    • Japan
    • India
    • Australia
    • South Korea
  • South America
    • Brazil
    • Argentina
    • Colombia
  • Middle East Africa
    • South Africa
    • Saudi Arabia
    • UAE
    • Kuwait

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Radiofrequency Ablation Devices Market.

Available Customizations:

Global Radiofrequency Ablation Devices marketreport with the given market data, Tech Sci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1.Product Overview

  • 1.1.Market Definition
  • 1.2.Scope of the Market
    • 1.2.1.Markets Covered
    • 1.2.2.Years Considered for Study
    • 1.2.3.Key Market Segmentations

2.Research Methodology

  • 2.1.Objective of the Study
  • 2.2.Baseline Methodology
  • 2.3.Key Industry Partners
  • 2.4.Major Association and Secondary Sources
  • 2.5.Forecasting Methodology
  • 2.6.Data Triangulation Validation
  • 2.7.Assumptions and Limitations

3.Executive Summary

  • 3.1.Overview of the Market
  • 3.2.Overview of Key Market Segmentations
  • 3.3.Overview of Key Market Players
  • 3.4.Overview of Key Regions/Countries
  • 3.5.Overview of Market Drivers, Challenges, Trends

4.Voice of Customer

5.Global Radiofrequency Ablation Devices Market Outlook

  • 5.1.Market Size Forecast
    • 5.1.1.By Value
  • 5.2.Market Share Forecast
    • 5.2.1.ByComponent Type (Disposable Equipment, Capital Equipment, Reusable Equipment)
    • 5.2.2.By Application (Surgical Oncology, Cardiology Cardiac Rhythm Management, Cosmetology, Gynecology, Pain Management)
    • 5.2.3.By End Use (Hospitals, Ambulatory Surgery Centers, Research Laboratories, Others)
    • 5.2.4.By Region
    • 5.2.5.By Company (2023)
  • 5.3.Market Map
    • 5.3.1.By Component Type
    • 5.3.2.By Application
    • 5.3.3.By End Use
    • 5.3.4.By Region

6.North America Radiofrequency Ablation Devices Market Outlook

  • 6.1.Market Size Forecast
    • 6.1.1.By Value
  • 6.2.Market Share Forecast
    • 6.2.1.By Component Type
    • 6.2.2.By Application
    • 6.2.3.By End Use
    • 6.2.4.By Country
  • 6.3.North America: Country Analysis
    • 6.3.1.United States Radiofrequency Ablation Devices Market Outlook
      • 6.3.1.1.Market Size Forecast
        • 6.3.1.1.1.By Value
      • 6.3.1.2.Market Share Forecast
        • 6.3.1.2.1.By Component Type
        • 6.3.1.2.2.By Application
        • 6.3.1.2.3.By End Use
    • 6.3.2.Canada Radiofrequency Ablation Devices Market Outlook
      • 6.3.2.1.Market Size Forecast
        • 6.3.2.1.1.By Value
      • 6.3.2.2.Market Share Forecast
        • 6.3.2.2.1.By Component Type
        • 6.3.2.2.2.By Application
        • 6.3.2.2.3.By End Use
    • 6.3.3.Mexico Radiofrequency Ablation Devices Market Outlook
      • 6.3.3.1.Market Size Forecast
        • 6.3.3.1.1.By Value
      • 6.3.3.2.Market Share Forecast
        • 6.3.3.2.1.By Component Type
        • 6.3.3.2.2.By Application
        • 6.3.3.2.3.By End Use

7.Europe Radiofrequency Ablation Devices Market Outlook

  • 7.1.Market Size Forecast
    • 7.1.1.By Value
  • 7.2.Market Share Forecast
    • 7.2.1.By Component Type
    • 7.2.2.By Application
    • 7.2.3.By End Use
    • 7.2.4.By Country
  • 7.3.Europe: Country Analysis
    • 7.3.1.Germany Radiofrequency Ablation Devices Market Outlook
      • 7.3.1.1.Market Size Forecast
        • 7.3.1.1.1.By Value
      • 7.3.1.2.Market Share Forecast
        • 7.3.1.2.1.By Component Type
        • 7.3.1.2.2.By Application
        • 7.3.1.2.3.By End Use
    • 7.3.2.United Kingdom Radiofrequency Ablation Devices Market Outlook
      • 7.3.2.1.Market Size Forecast
        • 7.3.2.1.1.By Value
      • 7.3.2.2.Market Share Forecast
        • 7.3.2.2.1.By Component Type
        • 7.3.2.2.2.By Application
        • 7.3.2.2.3.By End Use
    • 7.3.3.France Radiofrequency Ablation Devices Market Outlook
      • 7.3.3.1.Market Size Forecast
        • 7.3.3.1.1.By Value
      • 7.3.3.2.Market Share Forecast
        • 7.3.3.2.1.By Component Type
        • 7.3.3.2.2.By Application
        • 7.3.3.2.3.By End Use
    • 7.3.4.Italy Radiofrequency Ablation Devices Market Outlook
      • 7.3.4.1.Market Size Forecast
        • 7.3.4.1.1.By Value
      • 7.3.4.2.Market Share Forecast
        • 7.3.4.2.1.By Component Type
        • 7.3.4.2.2.By Application
        • 7.3.4.2.3.By End Use
    • 7.3.5.Spain Radiofrequency Ablation Devices Market Outlook
      • 7.3.5.1.Market Size Forecast
        • 7.3.5.1.1.By Value
      • 7.3.5.2.Market Share Forecast
        • 7.3.5.2.1.By Component Type
        • 7.3.5.2.2.By Application
        • 7.3.5.2.3.By End Use

8.Asia-Pacific Radiofrequency Ablation Devices Market Outlook

  • 8.1.Market Size Forecast
    • 8.1.1.By Value
  • 8.2.Market Share Forecast
    • 8.2.1.By Component Type
    • 8.2.2.By Application
    • 8.2.3.By End Use
    • 8.2.4.By Country
  • 8.3.Asia-Pacific: Country Analysis
    • 8.3.1.China Radiofrequency Ablation Devices Market Outlook
      • 8.3.1.1.Market Size Forecast
        • 8.3.1.1.1.By Value
      • 8.3.1.2.Market Share Forecast
        • 8.3.1.2.1.By Component Type
        • 8.3.1.2.2.By Application
        • 8.3.1.2.3.By End Use
    • 8.3.2.Japan Radiofrequency Ablation Devices Market Outlook
      • 8.3.2.1.Market Size Forecast
        • 8.3.2.1.1.By Value
      • 8.3.2.2.Market Share Forecast
        • 8.3.2.2.1.By Component Type
        • 8.3.2.2.2.By Application
        • 8.3.2.2.3.By End Use
    • 8.3.3.India Radiofrequency Ablation Devices Market Outlook
      • 8.3.3.1.Market Size Forecast
        • 8.3.3.1.1.By Value
      • 8.3.3.2.Market Share Forecast
        • 8.3.3.2.1.By Component Type
        • 8.3.3.2.2.By Application
        • 8.3.3.2.3.By End Use
    • 8.3.4.Australia Radiofrequency Ablation Devices Market Outlook
      • 8.3.4.1.Market Size Forecast
        • 8.3.4.1.1.By Value
      • 8.3.4.2.Market Share Forecast
        • 8.3.4.2.1.By Component Type
        • 8.3.4.2.2.By Application
        • 8.3.4.2.3.By End Use
    • 8.3.5.South Korea Radiofrequency Ablation Devices Market Outlook
      • 8.3.5.1.Market Size Forecast
        • 8.3.5.1.1.By Value
      • 8.3.5.2.Market Share Forecast
        • 8.3.5.2.1.By Component Type
        • 8.3.5.2.2.By Application
        • 8.3.5.2.3.By End Use

9.South America Radiofrequency Ablation Devices Market Outlook

  • 9.1.Market Size Forecast
    • 9.1.1.By Value
  • 9.2.Market Share Forecast
    • 9.2.1.By Component Type
    • 9.2.2.By Application
    • 9.2.3.By End Use
    • 9.2.4.By Country
  • 9.3.South America: Country Analysis
    • 9.3.1.Brazil Radiofrequency Ablation Devices Market Outlook
      • 9.3.1.1.Market Size Forecast
        • 9.3.1.1.1.By Value
      • 9.3.1.2.Market Share Forecast
        • 9.3.1.2.1.By Component Type
        • 9.3.1.2.2.By Application
        • 9.3.1.2.3.By End Use
    • 9.3.2.Argentina Radiofrequency Ablation Devices Market Outlook
      • 9.3.2.1.Market Size Forecast
        • 9.3.2.1.1.By Value
      • 9.3.2.2.Market Share Forecast
        • 9.3.2.2.1.By Component Type
        • 9.3.2.2.2.By Application
        • 9.3.2.2.3.By End Use
    • 9.3.3.Colombia Radiofrequency Ablation Devices Market Outlook
      • 9.3.3.1.Market Size Forecast
        • 9.3.3.1.1.By Value
      • 9.3.3.2.Market Share Forecast
        • 9.3.3.2.1.By Component Type
        • 9.3.3.2.2.By Application
        • 9.3.3.2.3.By End Use

10.Middle East and Africa Radiofrequency Ablation Devices Market Outlook

  • 10.1.Market Size Forecast
    • 10.1.1.By Value
  • 10.2.Market Share Forecast
    • 10.2.1.By Component Type
    • 10.2.2.By Application
    • 10.2.3.By End Use
    • 10.2.4.By Country
  • 10.3.MEA: Country Analysis
    • 10.3.1.South Africa Radiofrequency Ablation Devices Market Outlook
      • 10.3.1.1.Market Size Forecast
        • 10.3.1.1.1.By Value
      • 10.3.1.2.Market Share Forecast
        • 10.3.1.2.1.By Component Type
        • 10.3.1.2.2.By Application
        • 10.3.1.2.3.By End Use
    • 10.3.2.Saudi Arabia Radiofrequency Ablation Devices Market Outlook
      • 10.3.2.1.Market Size Forecast
        • 10.3.2.1.1.By Value
      • 10.3.2.2.Market Share Forecast
        • 10.3.2.2.1.By Component Type
        • 10.3.2.2.2.By Application
        • 10.3.2.2.3.By End Use
    • 10.3.3.UAE Radiofrequency Ablation Devices Market Outlook
      • 10.3.3.1.Market Size Forecast
        • 10.3.3.1.1.By Value
      • 10.3.3.2.Market Share Forecast
        • 10.3.3.2.1.By Component Type
        • 10.3.3.2.2.By Application
        • 10.3.3.2.3.By End Use
    • 10.3.4.Kuwait Radiofrequency Ablation Devices Market Outlook
      • 10.3.4.1.Market Size Forecast
        • 10.3.4.1.1.By Value
      • 10.3.4.2.Market Share Forecast
        • 10.3.4.2.1.By Component Type
        • 10.3.4.2.2.By Application
        • 10.3.4.2.3.By End Use

11.Market Dynamics

  • 11.1.Drivers
  • 11.2.Challenges

12.Market Trends Developments

  • 12.1.Recent Development
  • 12.2.Mergers Acquisitions
  • 12.3.Product Launches

13.Porter's Five Forces Analysis

  • 13.1.Competition in the Industry
  • 13.2.Potential of New Entrants
  • 13.3.Power of Suppliers
  • 13.4.Power of Customers
  • 13.5.Threat of Substitute Products

14.Competitive Landscape

  • 14.1.Boston Scientific Corporation
    • 14.1.1.Business Overview
    • 14.1.2.Product Service Offerings
    • 14.1.3.Recent Developments
    • 14.1.4.Key Personnel
    • 14.1.5.SWOT Analysis
  • 14.2.Medtronic plc
  • 14.3.Stryker Corporation
  • 14.4.Abbott Laboratories, Inc.
  • 14.5.Smith Nephew PLC
  • 14.6.Johnson Johnson
  • 14.7. AngioDynamics Inc

15.Strategic Recommendations

16. About Us Disclaimer

비교리스트
0 건의 상품을 선택 중
상품 비교하기
전체삭제